BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 148886)

  • 1. The cardiomyopathy of the Syrian hamster (strain BIO 8262)--hypertrophic or dystrophic?
    Mohr W; Lossnitzer K; Schwarz J
    Basic Res Cardiol; 1978; 73(1):34-46. PubMed ID: 148886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic changes in cardiomyopathic Syrian hamsters (strain BIO 8262).
    Lossnitzer K; Grewe N; Konrad A; Adler J
    Basic Res Cardiol; 1977; 72(4):421-35. PubMed ID: 143276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of enalapril on the collagen matrix in cardiomyopathic Syrian hamsters (Bio 14.6 and 53.58).
    Masutomo K; Makino N; Maruyama T; Shimada T; Yanaga T
    Jpn Circ J; 1996 Jan; 60(1):50-61. PubMed ID: 8648884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac carnitine deficiency and altered carnitine transport in cardiomyopathic hamsters.
    York CM; Cantrell CR; Borum PR
    Arch Biochem Biophys; 1983 Mar; 221(2):526-33. PubMed ID: 6838206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic connective tissue abnormalities in the heart muscle of cardiomyopathic Syrian hamsters.
    Cohen-Gould L; Robinson TF; Factor SM
    Am J Pathol; 1987 May; 127(2):327-34. PubMed ID: 3578490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural localization of calcium in the myocardium of cardiomyopathic syrian hamsters.
    Olbrich HG; Borgers M; Thoné F; Frotscher M; Mutschler E; Schneider M; Kober G; Kaltenbach M
    J Mol Cell Cardiol; 1988 Aug; 20(8):753-62. PubMed ID: 3221410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and biochemical studies on the heart of the cardiomyopathic Syrian hamster.
    Wada A; Yoneda R; Shibata N; Inui Y; Onishi S
    Recent Adv Stud Cardiac Struct Metab; 1975; 6():275-82. PubMed ID: 1197886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of increased alpha 1-adrenergic activity in cardiomyopathic Syrian hamster.
    Kagiya T; Hori M; Iwakura K; Iwai K; Watanabe Y; Uchida S; Yoshida H; Kitabatake A; Inoue M; Kamada T
    Am J Physiol; 1991 Jan; 260(1 Pt 2):H80-8. PubMed ID: 1671540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial subcellular fractionation studies on cardiomyopathic Syrian hamsters.
    Fitchett DH; Scott J; Stephens HR; Peters TJ
    Cardiovasc Res; 1979 May; 13(5):260-8. PubMed ID: 476746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in cardiac SR Ca(2+)-release channels during development of heart failure in cardiomyopathic hamsters.
    Ueyama T; Ohkusa T; Hisamatsu Y; Nakamura Y; Yamamoto T; Yano M; Matsuzaki M
    Am J Physiol; 1998 Jan; 274(1):H1-7. PubMed ID: 9458845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of alpha 1-adrenergic receptors and the effect of bunazosin on the histopathology of cardiomyopathic Syrian hamsters of strain BIO 14.6.
    Ikegaya T; Nishiyama T; Kobayashi A; Yamazaki N
    Jpn Circ J; 1988 Feb; 52(2):181-7. PubMed ID: 2896257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amino acid patterns in hereditary cardiomyopathy of Syrian golden hamsters (type BIO 8262)].
    Kaemmerer H; Fink-Gremmels J; Lossnitzer K; Rapp K
    Berl Munch Tierarztl Wochenschr; 1987 Oct; 100(10):340-6. PubMed ID: 3426533
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of L-carnitine and verapamil on myocardial carnitine concentration and histopathology of Syrian hamster BIO 14.6.
    Yamashita T; Kobayashi A; Yamazaki N; Miura K; Shirasawa H
    Cardiovasc Res; 1986 Aug; 20(8):614-20. PubMed ID: 3791351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac collagen remodeling in the cardiomyopathic Syrian hamster and the effect of losartan.
    Dixon IM; Ju H; Reid NL; Scammell-La Fleur T; Werner JP; Jasmin G
    J Mol Cell Cardiol; 1997 Jul; 29(7):1837-50. PubMed ID: 9236138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological changes of myocardial cytoskeleton in cardiomyopathic hamster.
    Kawaguchi N; Fujitani N; Schaper J; Onishi S
    Mol Cell Biochem; 1995 Mar; 144(1):75-9. PubMed ID: 7791749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in extracellular matrix components in cardiomyopathic Syrian hamster, BIO 14.6.
    Nogami K; Kusachi S; Niiya K; Moritani H; Tsuji T
    Jpn Circ J; 1995 Sep; 59(9):631-40. PubMed ID: 7500547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiomyopathic Syrian hamster: a possible model of human disease.
    Gertz EW
    Prog Exp Tumor Res; 1972; 16():242-60. PubMed ID: 4261129
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction of ventricular M2 muscarinic receptors in cardiomyopathic hamster (CHF 147) at the necrotic stage of the myopathy.
    Wilkinson M; Horackova M; Giles A
    Pflugers Arch; 1994 Apr; 426(6):516-23. PubMed ID: 8052521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters.
    Williams EB; Halpert I; Wickline S; Davison G; Parks WC; Rottman JN
    Circulation; 1995 Aug; 92(4):705-9. PubMed ID: 7641347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of beta-adrenoceptor subtype coupling to cardiac adenylyl cyclase in cardiomyopathic and control hamsters.
    Witte K; Schnecko A; Olbrich HG; Lemmer B
    Eur J Pharmacol; 1995 Jun; 290(1):1-10. PubMed ID: 7664819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.